title: The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation.
abstract: The incidence of osteosarcoma is increased 500-fold in patients who inherit mutations in the RB gene. To understand why the retinoblastoma protein (pRb) is specifically targeted in osteosarcoma, we studied its function in osteogenesis. Loss of pRb but not p107 or p130 blocks late osteoblast differentiation. pRb physically interacts with the osteoblast transcription factor, CBFA1, and associates with osteoblast-specific promoters in vivo in a CBFA1-dependent fashion. Association of pRb with CBFA1 and promoter sequences results in synergistic transactivation of an osteoblast-specific reporter. This transactivation function is lost in tumor-derived pRb mutants, underscoring a potential role in tumor suppression. Thus, pRb functions as a direct transcriptional coactivator promoting osteoblast differentiation, which may contribute to the targeting of pRb in osteosarcoma.
authors.affiliation: Department of Pathology and, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Thomas
authors.forename: S A
authors.initials: SA
authors.lastname: Carty
authors.forename: D M
authors.initials: DM
authors.lastname: Piscopo
authors.forename: J S
authors.initials: JS
authors.lastname: Lee
authors.forename: W F
authors.initials: WF
authors.lastname: Wang
authors.forename: W C
authors.initials: WC
authors.lastname: Forrester
authors.forename: P W
authors.initials: PW
authors.lastname: Hinds
mesh_terms: D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000494:pharmacology; D002454:Cell Differentiation / Q000502:physiology; D002478:Cells, Cultured; D050659:Core Binding Factor Alpha 1 Subunit; D017930:Genes, Reporter; D016161:Genes, Retinoblastoma; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D016297:Mutagenesis, Site-Directed; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000378:metabolism; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism; D015675:Osteocalcin / Q000235:genetics / Q000378:metabolism; D010012:Osteogenesis / Q000502:physiology*; D012516:Osteosarcoma / Q000235:genetics / Q000503:physiopathology; D050725:Papillomavirus E7 Proteins; D011401:Promoter Regions, Genetic / Q000502:physiology; D011485:Protein Binding; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins; D016160:Retinoblastoma Protein / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors / Q000378:metabolism*; D014158:Transcription, Genetic; D015533:Transcriptional Activation / Q000235:genetics / Q000502:physiology*; D016212:Transforming Growth Factor beta
chemical_list: C525718:BMP2 protein, human; C525719:Bmp2 protein, mouse; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D050659:Core Binding Factor Alpha 1 Subunit; D009363:Neoplasm Proteins; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D016160:Retinoblastoma Protein; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; C059731:oncogene protein E7, Human papillomavirus type 16; C499469:recombinant human bone morphogenetic protein-2; D015675:Osteocalcin